Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017;55(6):298-304.
doi: 10.5114/reum.2017.72627. Epub 2017 Dec 30.

Antinuclear antibodies in autoimmune and allergic diseases

Bogna Grygiel-Górniak  1 , Natalia Rogacka  1 , Michał Rogacki  2 , Mariusz Puszczewicz  1
Affiliations
Review

Antinuclear antibodies in autoimmune and allergic diseases

Bogna Grygiel-Górniak et al. Reumatologia. 2017.

Abstract

Antinuclear antibodies (ANA) are primarily significant in the diagnosis of systemic connective tissue diseases. The relationship between their occurrence in allergic diseases is poorly documented. However, the mechanism of allergic and autoimmune diseases has a common thread. In both cases, an increased production of IgE antibodies and presence of ANA in selected disease entities is observed. Equally important is the activation of basophils secreting proinflammatory factors and affecting the differentiation of TH17 lymphocytes. Both autoimmune and allergic diseases have complex multi-pathogenesis and often occur in genetically predisposed individuals. The presence of antinuclear antibodies was confirmed in many systemic connective tissue diseases and some allergic diseases. Examples include atopic dermatitis, non-allergic asthma, and pollen allergy. Co-occurring allergic and autoimmune disorders induce further search for mechanisms involved in the aetiopathogenesis of both groups of diseases.

Keywords: allergy; antinuclear antibodies; autoimmune diseases; molecular background.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Szczeklik A, Nizankowska E, Serafin A, et al. Autoimmune Phenomena in Bronchical Asthma with Special References to Aspirin Intolerance. Am J Respir Crit Care Med. 1995;152:1753–1756. - PubMed
    1. Nahm DH, Shin MJ, Yim H, et al. Increased levels of circulating autoantibodies to cultured human bronchial epithelial cell in adult patients with nonatopic asthma. J Korean Med Sci. 2001;16:407–410. - PMC - PubMed
    1. Comi AL, Tedeschi A, Lorini M, et al. Novel clinical and serological aspects in non-allergic asthma. Respir Med. 2007;101:2526–2533. - PubMed
    1. Asero R. Chronic idiopathic urticaria: a family study. Ann Allergy Asthma Immunol. 2002;89:195–196. - PubMed
    1. Pan Q, Gong L, Xiao H, et al. Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus. Front Immunol. 2017;27:348. - PMC - PubMed

LinkOut - more resources